← Open Payments lookup

MEGAN SIMPSON: Open Payments

NPI 1184145096 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$706 in 30 payments from 14 companies in 2025. Trend: 2023 $911 · 2024 $745 · 2025 $706

Food & beverage: $706
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP5$175
ABBVIE INC.9$161
Novo Nordisk Inc3$79
Novartis Pharmaceuticals Corporation2$53
PFIZER INC.2$33
Astellas Pharma US Inc1$33
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$33
Boston Scientific Corporation1$25
Amgen Inc.1$23
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$22

Products named: FARXIGA, QULIPTA, Wegovy, UBRELVY, NURTEC ODT, Veozah, CAPLYTA, AIRSUPRA.

Industry payments across NE — which companies pay providers there.